Sensient director granted 1,119 restricted shares
Sensient Technologies director Joseph Carleone reported an equity compensation grant and updated holdings.
Rhea-AI Filing Summary
Sensient Technologies director Joseph Carleone reported an equity compensation grant and updated holdings. On April 23, 2026, he received 1,119 shares of Common Stock as a grant of restricted stock under the issuer’s 2017 Stock Plan at a stated price of $0.0000 per share.
After this award, Carleone directly owns 23,670.313 shares of Common Stock, which include restricted shares and shares in a dividend reinvestment plan. He also holds Deferred Stock linked to 23,780.400 underlying shares of Common Stock, which convert one-for-one and will be issued when his board service ends.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 1,119 shares
Grant/Award
2 txns
Insider
Carleone Joseph
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,119 | $0.00 | $0.00 |
| holding | Deferred Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 23,670.313 shares (Direct);
Deferred Stock — 23,780.4 contracts (Direct)
Footnotes (4)
- F1. Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated.
- F2. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
- F3. Deferred stock converts to common stock on a one-for-one basis.
- F4. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.
Key Figures
Restricted stock grant: 1,119 shares
Post-grant common holdings: 23,670.313 shares
Deferred stock underlying shares: 23,780.400 shares
+1 more
4 metrics
Restricted stock grant
1,119 shares
Common Stock grant on April 23, 2026 under 2017 Stock Plan
Post-grant common holdings
23,670.313 shares
Total directly held Common Stock after transactions
Deferred stock underlying shares
23,780.400 shares
Common Stock underlying Deferred Stock, one-for-one conversion
Grant price
$0.0000 per share
Stated price for 1,119-share restricted stock grant
Key Terms
Deferred Stock, restricted stock, dividend reinvestment plan, 2017 Stock Plan
4 terms
Deferred Stock financial
"Deferred stock converts to common stock on a one-for-one basis."
restricted stock financial
"Represents grant of restricted stock under Issuer's 2017 Stock Plan"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
dividend reinvestment plan financial
"shares held in a dividend reinvestment plan."
A dividend reinvestment plan lets shareholders automatically use cash dividends to buy more shares of the same company instead of receiving the money. It matters to investors because it turns regular payouts into a steady way to grow ownership and take advantage of compound returns—like having your savings automatically buy additional slices of a pie over time—while often reducing transaction costs and smoothing purchase timing.
2017 Stock Plan financial
"under Issuer's 2017 Stock Plan, as amended and restated."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Sensient (SXT) director Joseph Carleone report in this Form 4?
Director Joseph Carleone reported receiving 1,119 shares of Common Stock as a grant of restricted stock on April 23, 2026. This award is part of equity compensation under Sensient Technologies’ 2017 Stock Plan, as amended and restated.
What are the terms of the restricted stock granted to Joseph Carleone at Sensient (SXT)?
The filing states Carleone was granted 1,119 restricted shares of Common Stock at a reported price of $0.0000 per share. The award was made under Sensient’s 2017 Stock Plan, as amended and restated, indicating it is part of board compensation rather than an open-market purchase.
What is the Deferred Stock position reported by Joseph Carleone at Sensient (SXT)?
Carleone holds Deferred Stock tied to 23,780.400 underlying shares of Common Stock. According to the footnotes, this deferred stock converts to common stock on a one-for-one basis, with shares issued when he ceases serving as a director.
Does the Form 4 for Sensient (SXT) show any stock sales by Joseph Carleone?
The data provided show an equity grant of 1,119 restricted shares and an updated Deferred Stock holding, but no reported stock sales. The transaction code for the grant is A, indicating a grant, award, or other acquisition of Common Stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
